on a mobile?
vTap
    Loading...
 
suggest
 
Video
July 30 - The diabetes drug Avandia should remain on the market, government health advisers recommended, saying evidence of an increased heart attack risk doesn't merit removal.
a year ago
AT&T
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Diabetes mellitus
Rosiglitazone
Go to Feed to see what's new!
share
keep
 
 
Increased risk of heart attacks linked to the use of the diabetes drug Avandia prompted an FDA panel Monday to add a black box warning to the drug according to CBS 5's Dr. Kim Mulvihill.
a year ago
CBS (cbs5 - San Francisco)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Black box warning
Food and Drug Administration
Myocardial infarction
Diabetes mellitus
Go to Feed to see what's new!
share
keep
 
 
An FDA panel says the popular diabetes drug Avandia may increase the risk of a heart attack. But the drug will remain on the market. Nancy Cordes reports.
2m 9s |
a year ago
CBS News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Myocardial infarction
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
A U.S. scientist for the Food and Drug Administration said on Monday that GlaxoSmithKline's diabetes drug Avandia must be pulled off the mar...
3m 21s |
a year ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rosiglitazone
GlaxoSmithKline
Pharmaceutical company
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
...Drug ...Avandia diabetes drug versus Takeda Pharmaceutical Co.'s Actos. Graham told a meeting of FDA advisers today that Avandia should be removed from the market because of heart risks. Avandia ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
Pioglitazone
David Graham (epidemiologist)
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Will the FDA yank the world's number-one selling diabetes drug from the market? They are about to make a critical decision on the potentially dangerous medication. CBS 2's Dr. Holly Phillips is here with more on the future of Avandia.
a year ago
CBS (New York)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Anti-diabetic drug
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use